Merck Enters MoU with Gene Therapy Research Institution
Merck, a leading science and technology company, has entered into a non-binding Memorandum of Understanding (MoU) with Gene Therapy Research Institution Co., Ltd. (GTRI), a Japanese biotech start-up focused on gene therapy using adeno-associated virus (AAV) vectors. Under this MoU,…